Viral Inactivation Using Improved Solvent-Detergent Method

1 - 85 . (canceled)

86 . A method of inactivating a lipid-coat containing virus, the method comprising the steps of:

a) providing a fluid comprising a Factor VIII having an activity;

b) mixing tri(n-butyl)phosphate, polyoxyethylene octyl phenyl, and polysorbate 80 sorbitan with the fluid, thereby creating a mixture, wherein the final concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about 5.0% (v/v), the final concentration of polyoxyethylene octyl phenyl is from about 0.5% (v/v) to about 10.0% (v/v), and the final concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about 5.0% (v/v); and

c) incubating the mixture for no more than about 120 minutes; wherein both steps (b) and (c) are performed at a temperature of no higher than about 12° C.;

wherein the mixture after incubation is essentially free of a viable lipid-coat containing virus; and

wherein the Factor VIII after incubation has an activity of at least 25% of the activity provided in step (a).

87 . The method of claim 86 , wherein the concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about.0.7%, the concentration of polyoxyethylene octyl phenyl is from about 0.6% (v/v) to about 1.4% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about.0.7%

88 . The method of claim 86 , wherein the concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about.0.5%, the concentration of polyoxyethylene octyl phenyl is from about 0.7% (v/v) to about 1.3% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about.0.5%

89 . The method of claim 86 , wherein the concentration of tri(n-butyl)phosphate is from about 0.2% (v/v) to about.0.4%, the concentration of polyoxyethylene octyl phenyl is from about 0.8% (v/v) to about 1.2% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.2% (v/v) to about.0.4%.

90 . The method of claim 86 , wherein the concentration of tri(n-butyl)phosphate is about 0.3% (v/v), the concentration of polyoxyethylene octyl phenyl is about 1.0% (v/v), and the concentration of polysorbate 80 sorbitan is about 0.3% (v/v).

91 . The method of claim 86 , wherein the mixture after incubation has less than about 1% of the protein having an activity in an aggregate form.

92 . The method of claim 86 , wherein the protein activity after incubation is at least 50% of the protein activity provided in step (a) or at least 75% of the protein activity provided in step (a).

93 . A Factor VIII essentially free of a lipid-coat containing virus obtained from a method comprising the steps of:

a) obtaining a fluid comprising a Factor VIII having an activity;

b) mixing tri(n-butyl)phosphate, polyoxyethylene octyl phenyl, and polysorbate 80 sorbitan with the fluid, thereby creating a mixture, wherein the final concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about 5.0% (v/v), the final concentration of polyoxyethylene octyl phenyl is from about 0.5% (v/v) to about 10.0% (v/v), and the final concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about 5.0% (v/v); and

c) incubating the mixture for no more than about 120 minutes; wherein both steps (b) and (c) are performed at a temperature of no higher than about 12° C.;

wherein the mixture after incubation is essentially free of a viable lipid-coat containing virus; and

wherein the Factor VIII after incubation has an activity of at least 25% of the activity provided in step (a).

94 . The Factor VIII of claim 93 , wherein the concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about.0.7%, the concentration of polyoxyethylene octyl phenyl is from about 0.6% (v/v) to about 1.4% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about.0.7%

95 . The Factor VIII of claim 93 , wherein the concentration of tri(n-butyl)phosphate is from about 0.1% (v/v) to about.0.5%, the concentration of polyoxyethylene octyl phenyl is from about 0.7% (v/v) to about 1.3% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.1% (v/v) to about.0.5%

96 . The Factor VIII of claim 93 , wherein the concentration of tri(n-butyl)phosphate is from about 0.2% (v/v) to about.0.4%, the concentration of polyoxyethylene octyl phenyl is from about 0.8% (v/v) to about 1.2% (v/v), and the concentration of polysorbate 80 sorbitan is from about 0.2% (v/v) to about.0.4%.

97 . The Factor VIII of claim 93 , wherein the concentration of tri(n-butyl)phosphate is about 0.3% (v/v), the concentration of polyoxyethylene octyl phenyl is about 1.0% (v/v), and the concentration of polysorbate 80 sorbitan is about 0.3% (v/v).

98 . The Factor VIII of claim 93 , wherein the mixture after incubation has less than about 1% of the protein having an activity in an aggregate form.

99 . The Factor VIII of claim 93 , wherein the protein activity is at least 50% of the protein activity provided in step (a) or at least 75% of the protein activity provided in step (a).

100 . A method of inactivating a lipid-coat containing virus, the method comprising the steps of:

a) providing a fluid comprising a blood protein having an activity;

b) mixing an alkylphosphate and at least two non-ionic surfactants with the fluid, thereby creating a mixture,

wherein the at least two non-ionic surfactants include a first non-ionic surfactant and a second non-ionic surfactant;

wherein the final concentration the alkylphosphate is from about 0.1% (v/v) to about 5.0% (v/v), the final concentration of the first non-ionic surfactant is from about 0.5% (v/v) to about 10.0% (v/v), and the final concentration of the second non-ionic surfactant is from about 0.1% (v/v) to about 5.0% (v/v); and

c) incubating the mixture for no more than about 120 minutes; wherein both steps (b) and (c) are performed at a temperature of no higher than about 20° C.;

wherein the mixture after incubation is essentially free of a viable lipid-coat containing virus; and

wherein the blood protein after incubation has an activity of at least 25% of the activity provided in step (a).

101 . The method of claim 100 , wherein the blood protein is ADAMTS-13, α1-antiplasmin, α2-antiplasmin, antithrombin, antithrombin III, cancer procoagulant, erythropoietin, Factor II, Factor V, Factor VI, Factor VII, Factor VIII, Factor IX, Factor X, Factor XI, Factor XII, Factor XIII, fibronectin, fibrinogen, heparin cofactor II, high-molecular-weight kininogen, intramuscular immunoglobulin, intravenous immunoglobulin, plasminogen, plasminogen activator inhibitor-1, plasminogen activator inhibitor-2, prekallikrein, protein C, protein S, protein Z, protein Z-related protease inhibitor, tissue factor, tissue plasminogen activator, urokinase, or Von Willebrand Factor.

102 . The method of claim 100 , wherein the alkylphosphate is a dialkylphosphate or a trialkylphosphate

103 . The method of claim 100 , wherein the first non-ionic surfactant is a polyoxyethylene glycol octylphenol ether.

104 . The method of claim 100 , wherein the second non-ionic surfactant is a polyoxyethylene glycol sorbitan alkyl ester.

105 . A blood protein essentially free of a lipid-coat containing virus obtained from a method comprising the steps of:

a) obtaining a fluid comprising a blood protein having an activity;

b) mixing an alkylphosphate, and at least two non-ionic surfactants with the fluid, thereby creating a mixture,

wherein the at least two non-ionic surfactants include a first non-ionic surfactant and a second non-ionic surfactant;

wherein the final concentration the alkylphosphate is from about 0.1% (v/v) to about 5.0% (v/v), the final concentration of the first non-ionic surfactant is from about 0.5% (v/v) to about 10.0% (v/v), and the final concentration of the second non-ionic surfactant is from about 0.1% (v/v) to about 5.0% (v/v); and

c) incubating the mixture for no more than about 120 minutes; wherein both steps (b) and (c) are performed at a temperature of no higher than about 20° C.;

wherein the mixture after incubation is essentially free of a viable lipid-coat containing virus; and

wherein the blood protein after incubation has an activity of at least 25% of the activity provided in step (a).